Compare MPLX LP (MPLX) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MPLX LP vs GeneDx Holdings Corp — how do they compare? MPLX LP trades at $59.9 (market cap $60.12B), while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: MPLX LP is far larger — about 24.6× GeneDx Holdings Corp's market cap, and MPLX LP pays a 7.26% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| MPLX | WGS | |
|---|---|---|
Market Cap | $60.12B | $2.44B |
Sector | Technology | Technology |
52-Week High | $60.51 | $167.51 |
52-Week Low | $47.80 | $34.51 |
Enterprise Value | $85.22B | $2.48B |
Dividend Yield | 7.26% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MPLX trades at $59.76, up 1.81% with a bullish technical outlook. The stock shows strong profitability with a 40.45% net income margin and a P/E of 12.75. Recent Q2 2026 earnings missed expectations, but revenue grew to $11.7B in 2026. The company announced a $2.25 billion senior notes offering on August 10, 2026, to fund growth projects, supporting its fee-based infrastructure model.
Outlook is positive with a consensus price target of $61.50, though risks include rising capital spending and leverage. The dividend yield remains attractive, with a $1.08 distribution declared for H2-2026. Investors should weigh solid cash flow against execution risks in expansion initiatives.
GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.
Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
